Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Nature Materials|April 15, 2014
Universal process-inert encoding architecture for polymer microparticlesJiseok Lee, Paul W Bisso, Rathi L Srinivas, et al.
Human Immunology|September 5, 2025
Proinflammatory phenotype can be critical in defining and modulating the genetic risk of non-syndromic hearing lossK P Sindura, M Sebastian, P Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Allosteric collaboration between elongation factor G and the ribosomal L1 stalk directs tRNA movements during translationJingyi Fei, Jonathan E Bronson, Jake M Hofman, et al.
IARC Scientific Publications|January 1, 1984
Role of specific membrane and genetic changes in the mechanism of tumour promotion. Studies with promoter-resistant variantsN H Colburn, L Srinivas, G A Hegamyer, et al.
Open Forum Infectious Diseases|February 21, 2022
Encephalitis Caused by Jamestown Canyon Virus in a Liver Transplant Patient, North Carolina, USA, 2017Emily J Ciccone, Alena J Markmann, Megan L Srinivas, et al.
Journal of Graduate Medical Education|October 7, 2011
Improving quality and patient satisfaction in a pediatric resident continuity clinic through advanced access schedulingSanjeev Y Tuli, Lindsay A Thompson, Kathleen A Ryan, et al.
Reproductive Health|December 20, 2021
Cognitive testing of a survey instrument to assess sexual practices, behaviours, and health outcomes: a multi-country study protocolLianne Gonsalves, Erin C Hunter, Vanessa Brizuela, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|July 5, 2008
Western blot detection of PrP Sc in archived paraffin-embedded brainstem from scrapie-affected sheepRobert A Kunkle, Eric M Nicholson, Semakaleng Lebepe-Mazur, et al.
Journal of Clinical Pharmacology|June 17, 2004
Safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally active novel camptothecin analog, DRF-1042, in refractory cancer patients in a phase I dose escalation studyArani Chatterjee, Raghunadharao Digumarti, Rao N V S Mamidi, et al.
Journal of Clinical Pharmacology|March 22, 2005
Safety, tolerability, and pharmacokinetics of a capsule formulation of DRF-1042, a novel camptothecin analog, in refractory cancer patients in a bridging phase I studyArani Chatterjee, Raghunadharao Digumarti, Kasiram Katneni, et al.
Pageof 6